High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast cancer: a therapy whose time has passed

[1]  L. Marks,et al.  A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and only bone metastases following intensive induction che , 2006, Bone Marrow Transplantation.

[2]  L. Marks,et al.  Consolidation with high-dose combination alkylating agents with bone marrow transplantation significantly improves disease-free survival in hormone-insensitive metastatic breast cancer in complete remission compared with intensive standard-dose chemotherapy alone. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[3]  T. Delozier,et al.  High-dose chemotherapy with haematopoietic stem cell transplantation for metastatic breast cancer patients: final results of the French multicentric randomised CMA/PEGASE 04 protocol. , 2005, European journal of cancer.

[4]  B. Asselain,et al.  High-dose chemotherapy for breast cancer: the French PEGASE experience. , 2003, Cancer control : journal of the Moffitt Cancer Center.

[5]  D. Berry,et al.  High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  C. Hudis,et al.  An on-site audit of the South African trial of high-dose chemotherapy for metastatic breast cancer and associated publications. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  J. Dancey,et al.  A randomized trial of high-dose chemotherapy (HDCT) with autologous peripheral blood stem cell support (asct) compared to standard chemo therapy (ct) in women with metastatic breast cancer: a National Cancer Institute of Canada (NCIC) clinical trials group study , 2001 .

[8]  S. Martino,et al.  Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group. , 2000, The New England journal of medicine.

[9]  Amela,et al.  CONVENTIONAL-DOSE CHEMOTHERAPY COMPARED WITH HIGH-DOSE CHEMOTHERAPY PLUS AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR METASTATIC BREAST CANCER , 2000 .

[10]  Th Lee.  Stem Cell Transplantation for Metastatic Breast Cancer , 1999 .

[11]  R. Mick,et al.  High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  B. Teicher,et al.  A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  R. Beveridge,et al.  High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer. , 1991, Journal of the National Cancer Institute.

[14]  R. Mick,et al.  High-dose consolidation therapy with autologous stem cell rescue in stage IV breast cancer. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  R. Bast,et al.  High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.